atai Life Sciences: Unparalleled Diversification With 10 Psychedelic Compounds Going Into Clinical Trials In 2022 May 25, 2022
Numinus’ Ongoing Collaboration With Health Canada Spurs Mindspace Clinic Approval In Quebec May 24, 2022
Trade To Black Podcast: Christian Angermayer Bullish On Psychedelic Sector And Life Extension Technology May 22, 2022
Awakn Life Sciences Completes The World’s First Ketamine Treatment Study For Behavioral Addictions May 20, 2022
InMed Pharmaceuticals: Commercializing The Development Of Rare Cannabinoids For The Wellness Market May 18, 2022
